Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_assertion type Assertion NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_head.
- NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_assertion description "[In early stages, concomitant expression of stromelysin 3 and Ets-1 favors the development of a precancerous state, whereas dual expression of stromelysin 3 and VEGF is associated with progression from precancerous to cancerous state.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_provenance.
- NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_assertion evidence source_evidence_literature NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_provenance.
- NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_assertion SIO_000772 15788677 NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_provenance.
- NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_assertion wasDerivedFrom befree-20150227 NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_provenance.
- NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_assertion wasGeneratedBy ECO_0000203 NP565389.RAuBjGBtw_laf0Itn8dEp4Vkt1PdRs4tf9e21UtZnxAH0130_provenance.